Maravai LifeSciences
MRVI
MRVI
227 hedge funds and large institutions have $6.27B invested in Maravai LifeSciences in 2021 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 91 increasing their positions, 55 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 195 → 227 (+32)
11.7% more ownership
Funds ownership: 100% → 111.7% (+12%)
26% less call options, than puts
Call options by funds: $13.8M | Put options by funds: $18.7M
Holders
227
Holding in Top 10
4
Calls
$13.8M
Puts
$18.7M
Top Buyers
| 1 | +$257M | |
| 2 | +$210M | |
| 3 | +$86.3M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$69.4M |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
+$58M |
Top Sellers
| 1 | -$144M | |
| 2 | -$124M | |
| 3 | -$67.1M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$51.2M |
| 5 |
HM
HealthCor Management
New York
|
-$49.4M |